Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Effects of Dapagliflozin on Circulating Markers of Phosphate Homeostasis.

de Jong MA, Petrykiv SI, Laverman GD, van Herwaarden AE, de Zeeuw D, Bakker SJL, Heerspink HJL, de Borst MH.

Clin J Am Soc Nephrol. 2019 Jan 7;14(1):66-73. doi: 10.2215/CJN.04530418. Epub 2018 Dec 17.

PMID:
30559106
2.

Daily oxytocin patterns in relation to psychopathy and childhood trauma in residential youth.

Fragkaki I, Verhagen M, van Herwaarden AE, Cima M.

Psychoneuroendocrinology. 2018 Dec 1;102:105-113. doi: 10.1016/j.psyneuen.2018.11.040. [Epub ahead of print]

3.

Quantification of Leydig cells and stromal hyperplasia in the postmenopausal ovary of women with endometrial carcinoma.

Reijnen C, Küsters-Vandevelde HVN, Abbink K, Zusterzeel PLM, van Herwaarden AE, van der Laak JAWM, Massuger LFAG, Snijders MPLM, Pijnenborg JMA, Bulten J.

Hum Pathol. 2018 Nov 11. pii: S0046-8177(18)30419-2. doi: 10.1016/j.humpath.2018.10.022. [Epub ahead of print]

PMID:
30428390
4.

Postoperative use of somatostatin analogs and mortality in patients with acromegaly.

Postma MR, Wolters TL, van den Berg G, van Herwaarden AE, Muller-Kobold A, Sluiter WJ, Wagenmakers MA, van den Bergh ACM, Wolffenbuttel BHR, Hermus A, Netea-Maier R, van Beek AP.

Eur J Endocrinol. 2018 Oct 1. pii: EJE-18-0166.R4. doi: 10.1530/EJE-18-0166. [Epub ahead of print]

PMID:
30400068
5.

Variable workup calls for guideline development for type 2A hereditary haemochromatosis.

Smit SL, Peters TMA, Gisbertz IAM, Moolenaar W, Hendriks Y, Vincent HH, Houtsma D, Loosveld OJL, van Herwaarden AE, Rennings AJM, Swinkels DW.

Neth J Med. 2018 Oct;76(8):365-373.

6.

A prediction model for primary aldosteronism when the salt loading test is inconclusive.

Velema M, Linssen E, Hermus A, Groenewoud H, van der Wilt GJ, van Herwaarden AE, Lenders J, Timmers HJLM, Deinum J.

Endocr Connect. 2018 Oct 1. pii: /journals/ec/aop/ec-18-0358.xml. doi: 10.1530/EC-18-0358. [Epub ahead of print]

7.

Saliva oxytocin, cortisol, and testosterone levels in adolescent boys with autism spectrum disorder, oppositional defiant disorder/conduct disorder and typically developing individuals.

Bakker-Huvenaars MJ, Greven CU, Herpers P, Wiegers E, Jansen A, van der Steen R, van Herwaarden AE, Baanders AN, Nijhof KS, Scheepers F, Rommelse N, Glennon JC, Buitelaar JK.

Eur Neuropsychopharmacol. 2018 Sep 7. pii: S0924-977X(18)30280-3. doi: 10.1016/j.euroneuro.2018.07.097. [Epub ahead of print]

PMID:
30201120
8.

Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge Gaps.

van der Galiën R, Ter Heine R, Greupink R, Schalkwijk SJ, van Herwaarden AE, Colbers A, Burger DM.

Clin Pharmacokinet. 2018 Jun 19. doi: 10.1007/s40262-018-0684-z. [Epub ahead of print] Review.

PMID:
29915921
9.

For Debate: Personalized Health Care: As Exemplified by Home Sodium Measurements in a Child with Central Diabetes Insipidus and Impaired Thirst Perception.

van der Linde AAA, van Herwaarden AE, Oosting JD, Claahsen-van der Grinten HL, de Grouw EPLM.

Pediatr Endocrinol Rev. 2018 Apr;15(4):276-279. doi: 10.17458/per.vol15.2018.lho.fd.CentralDiabetesInsipidus.

PMID:
29806747
10.

Gonadal function in adult male patients with congenital adrenal hyperplasia.

Engels M, Gehrmann K, Falhammar H, Webb EA, Nordenström A, Sweep FC, Span PN, van Herwaarden AE, Rohayem J, Richter-Unruh A, Bouvattier C, Köhler B, Kortmann BB, Arlt W, Roeleveld N, Reisch N, Stikkelbroeck NMML, Claahsen-van der Grinten HL; dsd-LIFE group.

Eur J Endocrinol. 2018 Mar;178(3):285-294. doi: 10.1530/EJE-17-0862. Epub 2018 Jan 16.

PMID:
29339528
11.

Falsely elevated plasma testosterone concentrations in neonates: importance of LC-MS/MS measurements.

Hamer HM, Finken MJJ, van Herwaarden AE, du Toit T, Swart AC, Heijboer AC.

Clin Chem Lab Med. 2018 May 24;56(6):e141-e143. doi: 10.1515/cclm-2017-1028. No abstract available.

PMID:
29306916
12.

GATA transcription factors in testicular adrenal rest tumours.

Engels M, Span PN, Mitchell RT, Heuvel JJTM, Marijnissen-van Zanten MA, van Herwaarden AE, Hulsbergen-van de Kaa CA, Oosterwijk E, Stikkelbroeck NM, Smith LB, Sweep FCGJ, Claahsen-van der Grinten HL.

Endocr Connect. 2017 Nov;6(8):866-875. doi: 10.1530/EC-17-0215. Epub 2017 Oct 16.

13.

Cardiovascular and metabolic risk in pediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency.

Mooij CF, van Herwaarden AE, Sweep FCGJ, Roeleveld N, de Korte CL, Kapusta L, Claahsen-van der Grinten HL.

J Pediatr Endocrinol Metab. 2017 Aug 28;30(9):957-966. doi: 10.1515/jpem-2017-0068.

PMID:
28787274
14.

Disorders of Adrenal Steroidogenesis: Impact on Gonadal Function and Sex Development.

Mooij CF, van Herwaarden AE, Claahsen-van der Grinten HL.

Pediatr Endocrinol Rev. 2016 Dec;14(2):109-128. doi: 10.17458/PER.2016.MEC.DisordersofAdrenal. Review.

PMID:
28508605
15.

Plasma galectin-3 concentrations in patients with primary aldosteronism.

van den Berg TNAD, Meijers WC, Donders ART, Van Herwaarden AE, Rongen GA, de Boer RA, Deinum J, Riksen NP.

J Hypertens. 2017 Sep;35(9):1849-1856. doi: 10.1097/HJH.0000000000001383.

PMID:
28403043
16.

Procollagen-3 N-terminal peptide measurements for the detection of liver fibrosis in methotrexate-treated patients with psoriasis: daily practice use and clinical implications.

van den Reek JMPA, Menting SP, Janssen WWL, Dhaliwal R, Heijboer AC, van Herwaarden AE, Sweep FCGJ, de Jong LM, Tjwa ET, Otero ME, Spuls PI, de Jong EMGJ.

Br J Dermatol. 2017 Nov;177(5):1454-1457. doi: 10.1111/bjd.15313. Epub 2017 Sep 10. No abstract available.

PMID:
28112796
17.

A method comparison of total and HMW adiponectin: HMW/total adiponectin ratio varies versus total adiponectin, independent of clinical condition.

van Andel M, Drent ML, van Herwaarden AE, Ackermans MT, Heijboer AC.

Clin Chim Acta. 2017 Feb;465:30-33. doi: 10.1016/j.cca.2016.12.009. Epub 2016 Dec 13.

PMID:
27986548
18.

Bilateral Testicular Tumors Resulting in Recurrent Cushing Disease After Bilateral Adrenalectomy.

Puar T, Engels M, van Herwaarden AE, Sweep FC, Hulsbergen-van de Kaa C, Kamphuis-van Ulzen K, Chortis V, Arlt W, Stikkelbroeck N, Claahsen-van der Grinten HL, Hermus AR.

J Clin Endocrinol Metab. 2017 Feb 1;102(2):339-344. doi: 10.1210/jc.2016-2702.

PMID:
27901643
19.

Differential Effects of Environmental and Genetic Factors on T and B Cell Immune Traits.

Aguirre-Gamboa R, Joosten I, Urbano PCM, van der Molen RG, van Rijssen E, van Cranenbroek B, Oosting M, Smeekens S, Jaeger M, Zorro M, Withoff S, van Herwaarden AE, Sweep FCGJ, Netea RT, Swertz MA, Franke L, Xavier RJ, Joosten LAB, Netea MG, Wijmenga C, Kumar V, Li Y, Koenen HJPM.

Cell Rep. 2016 Nov 22;17(9):2474-2487. doi: 10.1016/j.celrep.2016.10.053. Epub 2016 Nov 3.

20.

Host and Environmental Factors Influencing Individual Human Cytokine Responses.

Ter Horst R, Jaeger M, Smeekens SP, Oosting M, Swertz MA, Li Y, Kumar V, Diavatopoulos DA, Jansen AFM, Lemmers H, Toenhake-Dijkstra H, van Herwaarden AE, Janssen M, van der Molen RG, Joosten I, Sweep FCGJ, Smit JW, Netea-Maier RT, Koenders MMJF, Xavier RJ, van der Meer JWM, Dinarello CA, Pavelka N, Wijmenga C, Notebaart RA, Joosten LAB, Netea MG.

Cell. 2016 Nov 3;167(4):1111-1124.e13. doi: 10.1016/j.cell.2016.10.018.

21.

Various calibration procedures result in optimal standardization of routinely used 25(OH)D ID-LC-MS/MS methods.

Dirks NF, Vesper HW, van Herwaarden AE, van den Ouweland JM, Kema IP, Krabbe JG, Heijboer AC.

Clin Chim Acta. 2016 Nov 1;462:49-54. doi: 10.1016/j.cca.2016.08.016. Epub 2016 Aug 25.

22.

The value of Anti-Müllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization.

Reijnders IF, Nelen WL, IntHout J, van Herwaarden AE, Braat DD, Fleischer K.

Eur J Obstet Gynecol Reprod Biol. 2016 May;200:45-50. doi: 10.1016/j.ejogrb.2016.02.007. Epub 2016 Feb 27.

PMID:
26967346
23.

Evaluation of the highly sensitive Roche thyroglobulin II assay and establishment of a reference limit for thyroglobulin-negative patient samples.

Rotteveel-de Groot DM, Ross HA, Janssen MJR, Netea-Maier RT, Oosting JD, Sweep FCGJ, van Herwaarden AE.

Pract Lab Med. 2016 Mar 3;5:6-13. doi: 10.1016/j.plabm.2016.02.001. eCollection 2016 Aug 1.

24.

Comparison of eight routine unpublished LC-MS/MS methods for the simultaneous measurement of testosterone and androstenedione in serum.

Büttler RM, Martens F, Ackermans MT, Davison AS, van Herwaarden AE, Kortz L, Krabbe JG, Lentjes EG, Syme C, Webster R, Blankenstein MA, Heijboer AC.

Clin Chim Acta. 2016 Feb 15;454:112-8. doi: 10.1016/j.cca.2016.01.002. Epub 2016 Jan 8.

PMID:
26778410
25.

Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based study.

Eysbouts YK, Bulten J, Ottevanger PB, Thomas CM, Ten Kate-Booij MJ, van Herwaarden AE, Siebers AG, Sweep FC, Massuger LF.

Gynecol Oncol. 2016 Jan;140(1):70-5. doi: 10.1016/j.ygyno.2015.11.014. Epub 2015 Nov 14.

PMID:
26586414
26.

Adrenal Steroid Metabolites Accumulating in Congenital Adrenal Hyperplasia Lead to Transactivation of the Glucocorticoid Receptor.

Pijnenburg-Kleizen KJ, Engels M, Mooij CF, Griffin A, Krone N, Span PN, van Herwaarden AE, Sweep FC, Claahsen-van der Grinten HL.

Endocrinology. 2015 Oct;156(10):3504-10. doi: 10.1210/en.2015-1087. Epub 2015 Jul 24.

PMID:
26207344
27.

Molecular characterization of testicular adrenal rest tumors in congenital adrenal hyperplasia: lesions with both adrenocortical and Leydig cell features.

Smeets EE, Span PN, van Herwaarden AE, Wevers RA, Hermus AR, Sweep FC, Claahsen-van der Grinten HL.

J Clin Endocrinol Metab. 2015 Mar;100(3):E524-30. doi: 10.1210/jc.2014-2036. Epub 2014 Dec 8.

PMID:
25485724
28.

Pediatric urolithiasis in a non-endemic country: a single center experience from The Netherlands.

Rellum DM, Feitz WF, van Herwaarden AE, Schreuder MF.

J Pediatr Urol. 2014 Feb;10(1):155-61. doi: 10.1016/j.jpurol.2013.07.019. Epub 2013 Aug 24.

PMID:
23981680
29.

Reliable laboratory urinalysis results using a new standardised urine collection device.

Roelofs-Thijssen MA, Schreuder MF, Hogeveen M, van Herwaarden AE.

Clin Biochem. 2013 Sep;46(13-14):1252-6. doi: 10.1016/j.clinbiochem.2013.04.014. Epub 2013 Apr 26.

PMID:
23628593
30.

Second round robin for plasma hepcidin methods: first steps toward harmonization.

Kroot JJ, van Herwaarden AE, Tjalsma H, Jansen RT, Hendriks JC, Swinkels DW.

Am J Hematol. 2012 Oct;87(10):977-83. doi: 10.1002/ajh.23289. Epub 2012 Aug 7.

31.

Thyroid function in PMM2-CDG: diagnostic approach and proposed management.

Mohamed M, Theodore M, Claahsen-van der Grinten H, van Herwaarden AE, Huijben K, van Dongen L, Kouwenberg D, Lefeber DJ, Wevers RA, Morava E.

Mol Genet Metab. 2012 Apr;105(4):681-3. doi: 10.1016/j.ymgme.2012.02.001. Epub 2012 Feb 13.

PMID:
22386715
32.

Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity.

van Waterschoot RA, Lagas JS, Wagenaar E, van der Kruijssen CM, van Herwaarden AE, Song JY, Rooswinkel RW, van Tellingen O, Rosing H, Beijnen JH, Schinkel AH.

Cancer Res. 2009 Dec 1;69(23):8996-9002. doi: 10.1158/0008-5472.CAN-09-2915. Epub 2009 Nov 17.

33.

Influence of alpha-1 antitrypsin heterozygosity on treatment efficacy of HCV combination therapy.

Kok KF, van Soest H, van Herwaarden AE, van Oijen MG, Boland GJ, Halangk J, Berg T, de Vries RA, Drenth JP.

Eur J Gastroenterol Hepatol. 2010 Jul;22(7):808-12. doi: 10.1097/MEG.0b013e3283320113.

PMID:
19794310
34.

Inhibition and stimulation of intestinal and hepatic CYP3A activity: studies in humanized CYP3A4 transgenic mice using triazolam.

van Waterschoot RA, Rooswinkel RW, Sparidans RW, van Herwaarden AE, Beijnen JH, Schinkel AH.

Drug Metab Dispos. 2009 Dec;37(12):2305-13. doi: 10.1124/dmd.109.029397. Epub 2009 Sep 14.

35.

How important is intestinal cytochrome P450 3A metabolism?

van Herwaarden AE, van Waterschoot RA, Schinkel AH.

Trends Pharmacol Sci. 2009 May;30(5):223-7. doi: 10.1016/j.tips.2009.02.003. Epub 2009 Mar 28.

PMID:
19328560
36.

Intestinal cytochrome P450 3A plays an important role in the regulation of detoxifying systems in the liver.

van Waterschoot RA, Rooswinkel RW, Wagenaar E, van der Kruijssen CM, van Herwaarden AE, Schinkel AH.

FASEB J. 2009 Jan;23(1):224-31. doi: 10.1096/fj.08-114876. Epub 2008 Sep 15.

PMID:
18794335
37.

Midazolam metabolism in cytochrome P450 3A knockout mice can be attributed to up-regulated CYP2C enzymes.

van Waterschoot RA, van Herwaarden AE, Lagas JS, Sparidans RW, Wagenaar E, van der Kruijssen CM, Goldstein JA, Zeldin DC, Beijnen JH, Schinkel AH.

Mol Pharmacol. 2008 Mar;73(3):1029-36. Epub 2007 Dec 21.

38.

Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism.

van Herwaarden AE, Wagenaar E, van der Kruijssen CM, van Waterschoot RA, Smit JW, Song JY, van der Valk MA, van Tellingen O, van der Hoorn JW, Rosing H, Beijnen JH, Schinkel AH.

J Clin Invest. 2007 Nov;117(11):3583-92.

39.

Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk.

van Herwaarden AE, Wagenaar E, Merino G, Jonker JW, Rosing H, Beijnen JH, Schinkel AH.

Mol Cell Biol. 2007 Feb;27(4):1247-53. Epub 2006 Dec 4.

40.

The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins.

van Herwaarden AE, Schinkel AH.

Trends Pharmacol Sci. 2006 Jan;27(1):10-6. Epub 2005 Dec 6. Review.

PMID:
16337280
41.

Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk.

van Herwaarden AE, Wagenaar E, Karnekamp B, Merino G, Jonker JW, Schinkel AH.

Carcinogenesis. 2006 Jan;27(1):123-30. Epub 2005 Jul 6.

PMID:
16000399
42.

Midazolam and cyclosporin a metabolism in transgenic mice with liver-specific expression of human CYP3A4.

van Herwaarden AE, Smit JW, Sparidans RW, Wagenaar E, van der Kruijssen CM, Schellens JH, Beijnen JH, Schinkel AH.

Drug Metab Dispos. 2005 Jul;33(7):892-5. Epub 2005 Apr 21.

43.

Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver.

Merino G, van Herwaarden AE, Wagenaar E, Jonker JW, Schinkel AH.

Mol Pharmacol. 2005 May;67(5):1765-71. Epub 2005 Feb 18.

44.

The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin.

Merino G, Jonker JW, Wagenaar E, van Herwaarden AE, Schinkel AH.

Mol Pharmacol. 2005 May;67(5):1758-64. Epub 2005 Feb 11.

45.

The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk.

Jonker JW, Merino G, Musters S, van Herwaarden AE, Bolscher E, Wagenaar E, Mesman E, Dale TC, Schinkel AH.

Nat Med. 2005 Feb;11(2):127-9. Epub 2005 Jan 30.

46.

The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

van Herwaarden AE, Jonker JW, Wagenaar E, Brinkhuis RF, Schellens JH, Beijnen JH, Schinkel AH.

Cancer Res. 2003 Oct 1;63(19):6447-52.

Supplemental Content

Loading ...
Support Center